Short description
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies.
Description
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer.
Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer.
Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Baltimore, Maryland, United States, North America
Founded on
January 1, 2010
Exited on
December 23, 2021
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Absolutely Noaccess, Nopepepe, Cannot Access, Noaccessforu, Noaccess, Absolutely Noaccess, Nopepepe, Noaccess, Noaccess, Noaccessforu, Absolutely Noaccess, Nopepepe, Blurry Noaccess, Noway Youcantaccess, Nopepepe, Noway Youcantaccess, Absolutely Noaccess
Sign in for full access
Founders
Luis Diaz, Victor Velculescu, Victor Velculescu